Search results
Results from the WOW.Com Content Network
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent ...
AstraZeneca said that the agreements effectively resolve all pending claims against it for failing to warn pa. AstraZeneca did not disclose specific terms of the agreement and said in a statement ...
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [14]
AstraZeneca is advancing early stage trials of several cell therapies in different types of cancer including liver and prostate cancer. (Reporting by Sriparna Roy in Bengaluru; Editing by Shounak ...
The US Food and Drug Administration (FDA) approved durvalumab for certain types of bladder, lung, and biliary tract cancer: [6] [13] [14]. Adults with locally advanced or metastatic urothelial carcinoma who either have disease progression during or following platinum-containing chemotherapy or have disease progression within twelve months of neoadjuvant or adjuvant treatment with platinum ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
AstraZeneca, according to the lawsuit, offered Dressen $1,243.30 and is leaving her with a heavy financial burden that is costing hundreds of thousands of dollars, the complaint says.
The international nonproprietary name of the drug was inspired by that of Thor's hammer, Mjölnir. The idea is that the drug will strike down the virus like a mighty blow from the god of thunder. [30] In 2019, the National Institute of Allergy and Infectious Diseases (NIAID) approved moving molnupiravir into Phase I clinical trials for ...